Advancing Innovation in Blood Cancer Care for Better Patient Outcomes – Bristol Myers Squibb
Bristol Myers Squibb/bms.com

Advancing Innovation in Blood Cancer Care for Better Patient Outcomes – Bristol Myers Squibb

Bristol Myers Squibb shared on LinkedIn:

“From pioneering research to developing next-generation therapies, our commitment to hematology runs deep.

Every three minutes, someone is diagnosed with a form of blood cancer in the U.S. Each diagnosis represents a parent, family member, a colleague or friend navigating this change.

Join us this month as we honor the strength of the blood cancer community, share stories of hope and reinforce our promise to pursue better patient outcomes.

Read further here.

You may also be interested in: Blood Cancer United Academic Clinical Trials Program 2026–27

Advancing Innovation in Blood Cancer Care for Better Patient Outcomes - Bristol Myers Squibb